AC Immune

$6.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.33 (-4.67%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AC Immune and other stocks, options, and ETFs commission-free!

About ACIU

AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

CEO
Andrea Pfeifer
Employees
149
Headquarters
Lausanne, Vaud
Founded
2003
Market Cap
462.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
182.48K
High Today
$7.04
Low Today
$6.70
Open Price
$7.04
Volume
131.04K
52 Week High
$13.00
52 Week Low
$4.42

ACIU Earnings

-$0.28
-$0.10
$0.08
$0.26
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 28, Pre-Market

You May Also Like

XLC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure